Cholecystokinin (CCK): Several studies emphasized CCK’s panicogenic effect in humans and this neuropeptide satisfied most of the criteria for an “ideal” challenge substance for PDA [121,122,123]. Here, CCK is linked to Patent ductus arteriosus.